Total submissions: 5
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Genomic Research Center, |
RCV001169968 | SCV001251682 | likely pathogenic | not provided | 2020-05-03 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV001169968 | SCV001546852 | uncertain significance | not provided | 2024-09-09 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 2158 of the COL7A1 protein (p.Arg2158His). This variant is present in population databases (rs138626345, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with COL7A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 915364). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on COL7A1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| Revvity Omics, |
RCV001169968 | SCV003828282 | uncertain significance | not provided | 2019-12-30 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV004032917 | SCV004930047 | uncertain significance | Inborn genetic diseases | 2023-12-11 | criteria provided, single submitter | clinical testing | The c.6473G>A (p.R2158H) alteration is located in exon 79 (coding exon 79) of the COL7A1 gene. This alteration results from a G to A substitution at nucleotide position 6473, causing the arginine (R) at amino acid position 2158 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
| Natera, |
RCV001279702 | SCV001466821 | uncertain significance | Epidermolysis bullosa dystrophica inversa, autosomal recessive | 2020-10-08 | no assertion criteria provided | clinical testing |